Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Factors Associated with Antiviral Drug Use Among Commercially Insured Children at High Risk for Complications of Influenza

The Journal of Pediatrics(2025)10.1016/j.jpeds.2025.114574Source: DataRank Database

Factors Associated with Antiviral Drug Use Among Commercially Insured Children at High Risk for Complications of Influenza is a research paper published in The Journal of Pediatrics (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.69)OA: hybridTopics (54)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Jyotirmoy Sarker ORCID,Pei-Wen Lien,Derek J. Williams ORCID,Carlos G. Grijalva ORCID,Todd A. Lee ORCID

Live enrichment

PubMed:40185310 PMC:PMC12158634 OpenAlex:https://openalex.org/W4409126811

NIAID NIH HHS

Grant: K23 AI168496

NIAID NIH HHS

Grant: K24 AI148459

AstraZeneca

National Institute of Allergy and Infectious Diseases

National Institute of Allergy and Infectious Diseases Division of Intramural Research

National Institutes of Health

FWCI

0.69

Citation Percentile

0.7%

Citation Trend

2025

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.jpeds.2025.114574

publisherhttps://doi.org/10.1016/j.jpeds.2025.114574

publisherhttps://api.elsevier.com/content/article/PII:S0022347625001143?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022347625001143?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40185310

Fields of Study

Influenza Virus Research StudiesRespiratory viral infections researchViral Infections and Immunology ResearchHumansInfluenza, HumanAntiviral AgentsRetrospective StudiesFemaleChild, PreschoolMaleChildInfantUnited StatesAdolescentZanamivirOseltamivirRisk FactorsInsurance, HealthTriazinesDibenzothiepinsMorpholinesPyridones

MeSH Terms

AdolescentAntiviral AgentsChildChild, PreschoolDibenzothiepinsFemaleHumansInfantInfluenza, HumanInsurance, HealthMaleMorpholinesPyridonesRetrospective StudiesRisk FactorsTriazinesUnited StatesOseltamivirZanamivir

Keywords

MedicineDrugAntiviral drugAntiviral treatmentIntensive care medicineVirologyPharmacologyVirusInfluenzaAntiviralOseltamivirPediatricsBaloxavir

Sustainable Development Goals

SDG 0: Good health and well-being

Factors Associated with Antiviral Drug Use Among Commercially Insured Children at High Risk for Complications of Influenza

FAIR Checklist

Authors (7)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)